PD-L1 expression and its relationship with other driver genes in non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Jiang, Liyan
Su, Xinying
Zhang, Tianwei
Yin, Xiaolu
Zhang, Meizhuo
Fu, Haihua
Han, Hulin
Sun, Yun
Dong, Lili
Qian, Jialin
Xu, Yanhua
Fu, Xuan
Gavine, Paul
Zhou, Yanbin
Kun, Tian
Huang, Jiaqi
Jiang, Haiyi
Yao, Yihong
Han, Baohui
Gu, Yi
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-5140
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5140
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Effect of neoadjuvant chemoimmunotherapy on PD-L1 expression in non-small cell lung cancer
    Stoykova, S.
    Chriqui, L.
    Berchtold, E. Abdelnour
    Peters, S.
    Perentes, J. Y.
    Berezowska, S.
    VIRCHOWS ARCHIV, 2024, 485 : S20 - S20
  • [42] Liquid Biopsy Based Monitoring of PD-L1 Expression in Non-Small Cell Lung Cancer (NSCLC) Patients for Immunotherapy
    Singh, G.
    Leong, M.
    Sylvester, S.
    Lee, Y.
    Johnson, C.
    Wu, A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (06): : 1006 - 1006
  • [43] PD-L1 expression by RNA-sequencing and survival from pembrolizumab in non-small cell lung cancer (NSCLC)
    Nesline, Mary K.
    Pabla, Sarabjot
    Lee, Yong Hee
    DePietro, Paul
    Early, Amy
    Klein, Roger
    Zhang, Shengle
    Conroy, Jeffrey
    CANCER RESEARCH, 2022, 82 (12)
  • [44] Common Oncogenic Driver Mutations and PD-L1 Expression in Non-Small Cell Lung Cancer of Smokers and Never Smokers
    Liam, C. K.
    Yew, C. Y.
    Pang, Y. K.
    Wong, C. K.
    Poh, M. E.
    Tan, J. L.
    Soo, C. I.
    Loh, T. C.
    Chin, K. K.
    Munusamy, V.
    Ibrahim, N. H.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1141 - S1142
  • [45] Screening for PD-L1 expression by immunohistochemistry in non-small cell lung cancer (NSCLC) in the era of immunotherapy: a national study
    Breen, K.
    McCormack, J.
    Fabre, A.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 (SUPPL 10) : S417 - S418
  • [46] Role of EBUS-TBNA in the study of PD-L1 expression in patients with non-small cell lung cancer (NSCLC)
    Puig Sanchez, Francisco Guillermo
    Roman Rodriguez, Lucas
    Barca Hernando, Maria
    Marquez Martin, Eduardo
    Romero Romero, Beatriz
    Martin Juan, Jose
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [47] Characterization of PD-L1 expression in circulating tumor cells (CTCs) of non-small cell lung cancer (NSCLC) patients
    Krupa, R.
    Lu, D.
    Harvey, M.
    Louw, J.
    Jendrisak, A.
    Marrinucci, D.
    Dittamore, R.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 45 - 45
  • [48] PD-L1 expression for advanced non-small cell lung cancer patients with cancer cachexia
    Morimoto, Kenji
    Yamada, Tadaaki
    CANCER SCIENCE, 2023, 114 : 1410 - 1410
  • [49] Spatial heterogeneity of PD-L1 expression and the risk for misclassification of PD-L1 immunohistochemistry in non-small cell lung cancer
    Dori, Shani Ben
    Aizic, Asaf
    Sabo, Edmond
    Hershkovitz, Dov
    LUNG CANCER, 2020, 147 : 91 - 98
  • [50] Spatiotemporal Effects on Programmed Death Ligand 1 (PD-L1) Expression and Immunophenotype of Non-Small Cell Lung Cancer (NSCLC)
    Kowanetz, Marcin
    Koeppen, Hartmut
    Boe, Marigold
    Chaft, Jamie E.
    Rudin, Charles M.
    Zou, Wei
    Nickles, Dorothee
    Desai, Rupal
    Nakamura, Rin
    Sandler, Alan
    Amler, Lukas
    Hegde, Priti
    Rizvi, Naiyer A.
    Hellmann, Matthew D.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S199 - S199
12345